Innoviva Inc. (INVA)
NASDAQ: INVA
· Real-Time Price · USD
17.48
-0.18 (-0.99%)
At close: Oct 03, 2025, 3:59 PM
17.48
0.00%
After-hours: Oct 03, 2025, 04:20 PM EDT
Innoviva Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| License And Other Revenue Revenue | 910K | 546K | 28.93M | 27.82M | 21.65M | 19.08M | 19.68M | 13.7M | 15.73M | 11.51M | 14.59M | 5.11M | 42.72M | 29.31M | 329.89M | 35.59M | 26.39M |
| License And Other Revenue Revenue Growth | +66.67% | -98.11% | +4.00% | +28.50% | +13.45% | -3.00% | +43.60% | -12.88% | +36.59% | -21.07% | +185.63% | -88.05% | +45.76% | -91.12% | +827.06% | +34.86% | n/a |
| Product Revenue | 35.49M | 30.28M | 62.52M | 57.06M | 63.74M | 58.41M | 66.17M | 53.56M | 62.27M | 56.86M | 51.22M | n/a | n/a | n/a | n/a | n/a | n/a |
| Product Revenue Growth | +17.22% | -51.57% | +9.58% | -10.49% | +9.12% | -11.71% | +23.54% | -13.98% | +9.51% | +11.02% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Royalty Revenue | 63.88M | 57.81M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Royalty Revenue Growth | +10.51% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 26.41M | 27.49M | 31.33M | 26.22M | 27.72M | 30.35M | 26.27M | 28.64M | 23.54M | 19.73M | 17.39M | 27.81M | 11.78M | 6.49M | 3.11M | 2.86M | 4.23M | 5.99M | 5.47M | 3.25M | 2.6M | 2.56M | 2.33M | 4.96M | 4.35M | 3.02M | 2.64M | 4.02M | 4.41M | 8.51M | 5.69M | 5.82M | 6.08M | 6.56M | 5.61M | 5.11M | 6.22M | 6.25M | 4.82M | 4.58M | 4.91M | 5.44M |
| Selling, General, and Administrative Revenue Growth | -3.92% | -12.24% | +19.48% | -5.41% | -8.67% | +15.55% | -8.27% | +21.64% | +19.29% | +13.48% | -37.47% | +136.04% | +81.48% | +108.54% | +8.85% | -32.36% | -29.37% | +9.43% | +68.10% | +25.35% | +1.29% | +9.91% | -53.00% | +14.15% | +44.18% | +14.29% | -34.36% | -8.89% | -48.17% | +49.58% | -2.27% | -4.20% | -7.33% | +16.98% | +9.81% | -17.99% | -0.43% | +29.68% | +5.24% | -6.68% | -9.74% | n/a |
| Research and Development Revenue | 7.98M | 4.4M | 3.67M | 3.55M | 2.56M | 3.88M | 2.36M | 3.99M | 14.99M | 12.59M | 10.05M | 11.72M | 13.88M | 5.84M | 40K | 449K | 38K | 49K | 219K | 1.01M | 559K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 342K | 311K | 348K | 354K | 345K | 286K | 370K | 392K | 722K | 547K | 638K | 712K |
| Research and Development Revenue Growth | +81.60% | +19.95% | +3.21% | +38.71% | -33.99% | +64.60% | -40.94% | -73.39% | +19.07% | +25.27% | -14.29% | -15.55% | +137.82% | +14495.00% | -91.09% | +1081.58% | -22.45% | -77.63% | -78.32% | +80.68% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -100.00% | +9.97% | -10.63% | -1.69% | +2.61% | +20.63% | -22.70% | -5.61% | -45.71% | +31.99% | -14.26% | -10.39% | n/a |